MDRX

Veradigm Inc.
3 filings tracked
healthcarehealthcare itSMALL ($300M-2B)

Signal Magnitude Chart

BEARISH | 90% | 5/26/2026 | margin compressionBEARISH | 70% | 5/26/2026 | debt restructureNEUTRAL | 40% | 5/26/2026 | management changeNEUTRAL | 30% | 5/26/2026 | management changeBULLISH | 60% | 5/26/2026 | guidance raiseNEUTRAL | 40% | 5/26/2026 | management changeBEARISH | 70% | 5/26/2026 | regulatory actionMay 26May 26HIGHLOW
bullish
bearish
neutral

Signal Timeline

bearishMay 26

Gross margins fell from 54.6% to 50.8% year-over-year.

margin compression
90%
bearishMay 26

Effective interest rate on convertible notes surged to 7.24% from 2.55%.

debt restructure
70%
neutralMay 26

Company is operating with an Interim Chief Financial Officer.

management change
40%
neutralMay 26

Company is improving financial reporting transparency through delayed filings.

management change
30%
bullishMay 26

Reaffirmation of 2025 preliminary estimates suggests stability in growth.

guidance raise
60%
neutralMay 26

Formalization of transition from interim to permanent CFO via strategic advisor.

management change
40%
bearishMay 26

Explicit admission of material weaknesses in internal control over financial reporting.

regulatory action
70%

Filing History

10-KMay 26, 2026

Veradigm's 10-K presents a company at a critical inflection point, where the ability to monetize its software transition must outpace its accelerating cash burn. While the shift toward a recurring revenue model and the cleaning of the balance sheet provide a theoretical foundation for recovery, the immediate financial data shows significant stress in both profitability and liquidity. The overarching impact for investors is a high-risk trade-off between the potential for a successful platform pivot and the reality of deteriorating margins. The company's success now depends on whether the growth in first-year contract values can translate into actual bottom-line recovery before the weight of its high-interest debt becomes unsustainable.

8-KMay 26, 2026

The May 26 filing represents a pivotal moment for Veradigm as it attempts to bridge a significant information gap for shareholders. While the provision of multi-year financial data is a necessary step toward corporate maturity and transparency, the unaudited nature of the most recent projections leaves a window of uncertainty. The overall impact depends on whether the finalized audits align with the preliminary estimates provided in the press release; a match would confirm a recovery narrative, while a discrepancy would validate concerns regarding management's accounting integrity.

8-KMay 26, 2026

Veradigm's filing reveals a company in a critical transition phase, attempting to bridge the gap between operational instability and regulatory compliance. The appointment of a strategic advisor to clean up internal controls and finalize overdue filings is a necessary step, but the terms of the agreement highlight the severity of the existing accounting deficiencies. The market's reaction will likely depend on whether these measures result in clean, timely filings or if the rush to comply exposes further financial irregularities. Ultimately, the filing underscores that while the path to stability is mapped, the execution risk remains high.